Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329 SHG) stock market data APIs
¥45.5371
-2.19(-4.8%)
as of October 31, 2025
Try our APIs with
free plan!
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Financial Data Overview
Price chart is built with
Anychart
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company manufactures and sells of biochemical pharmaceutical products. It also engages in research and development of chinese patent medicines, chemical raw materials and preparations, and nutritional supplements. In addition, the company is involved in pharmaceutical and drug retail business. Further, it offers Suxiao Jiuxin pills, Qingyan drop pills, Jingwanhong ointment, Angong Niuhuang pills, Qingfei pills, anti-inflammatory pills, Qinggong Shoutao pills, Biqi capsules, Niuhuang Qingxin pills, Tongmai Yangxin pills, and Weichang An pills. Additionally, the company pharmaceutical logistic services. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1981 and is based in Tianjin, the People's Republic of China.
Prev. Close
45.5371
Open
43.3501
High
46.2778
Low
43.3501
52 wk Range
28.53-50.97
Market Cap
30 266 M
P/E Ratio
10.163
Shares Outstanding
570 M
Revenue
5 993 M
EPS
0.4184
Dividends (Yield)
0.0304
Beta
0.794
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Tianjin Zhongxin Pharmaceutical Group Corp Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tianjin Zhongxin Pharmaceutical Group Corp Ltd data using free add-ons & libraries
Get Tianjin Zhongxin Pharmaceutical Group Corp Ltd Fundamental Data
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Fundamental data includes:
- Net Revenue: 5 993 M
- EBITDA: 932 M
- Earnings Per Share: 4
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Tianjin Zhongxin Pharmaceutical Group Corp Ltd Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2023-08-14
- EPS/Forecast: NaN
Get Tianjin Zhongxin Pharmaceutical Group Corp Ltd End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tianjin Zhongxin Pharmaceutical Group Corp Ltd News
New
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SGX:T14) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) has had a rough three months with its share price down 10%. However, a closer look at its sound financials might cause you to think again. Given that...
If EPS Growth Is Important To You, Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Presents An Opportunity
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the r...
Retail investors are Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SGX:T14) biggest owners and were hit after market cap dropped US$139m
Key Insights The considerable ownership by retail investors in Tianjin Pharmaceutical Da Ren Tang Group indicates that they collectively have a greater say in management and business strategy The top...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
